ENANTA PHARMACEUTICALS INC - COM (ENTA)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
22M
Holdings value Q2 2024
$285M
Value change Q2 2024
-$4.64M
Grand Portfolio weight change Q2 2024
0%
Number of holders
98
Number of buys Q2 2024
17
Number of sells Q2 2024
-12
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 646K $6.69M -$1.34M $10.36 26
2024 Q2 22M $285M -$4.64M $12.97 98
2024 Q1 22.3M $389M +$45.3M $17.46 104
2023 Q4 19.9M $187M -$5.41M $9.41 102
2023 Q3 20M $224M -$8.7M $11.17 128
2023 Q2 19.8M $425M -$15.8M $21.40 127
2023 Q1 19.7M $798M +$23.7M $40.44 141
2022 Q4 19.1M $890M -$45.7M $46.52 144
2022 Q3 19.6M $1.02B -$26.6M $51.87 154
2022 Q2 20.2M $953M +$17.3M $47.27 150
2022 Q1 19.6M $1.39B +$55.4M $71.18 163
2021 Q4 18.8M $1.4B -$51.4M $74.78 174
2021 Q3 19.4M $1.1B +$34.6M $56.81 142
2021 Q2 18.8M $829M -$26.9M $44.01 149
2021 Q1 19.4M $957M +$7.4M $49.32 147
2020 Q4 19.3M $811M +$16.5M $42.10 148
2020 Q3 18.9M $863M +$27.2M $45.78 170
2020 Q2 18.3M $917M +$10.6M $50.21 172
2020 Q1 18M $927M -$32.4M $51.43 153
2019 Q4 18.4M $1.14B +$22M $61.78 166
2019 Q3 17.9M $1.07B +$8.73M $60.08 170
2019 Q2 17.6M $1.49B -$2.59M $84.38 191
2019 Q1 17.8M $1.7B +$94.8M $95.52 194
2018 Q4 16.8M $1.19B +$7.02M $70.83 179
2018 Q3 16.6M $1.42B +$118M $85.46 194
2018 Q2 15.1M $1.75B +$46.8M $115.90 189
2018 Q1 14.7M $1.19B +$62.5M $80.91 177
2017 Q4 14M $822M +$75.2M $58.68 141
2017 Q3 12.8M $597M +$18.4M $46.80 120
2017 Q2 12.6M $454M -$5.67M $35.98 118
2017 Q1 12.8M $396M +$44.7M $30.80 123
2016 Q4 13.3M $444M +$17.8M $33.50 146
2016 Q3 13.1M $349M +$1.15M $26.61 134
2016 Q2 13.4M $296M -$1.37M $22.05 125
2016 Q1 14.2M $418M -$10.1M $29.37 151
2015 Q4 14.6M $483M -$21.1M $33.02 133
2015 Q3 14.5M $525M +$42M $36.14 140
2015 Q2 13.8M $621M +$78.9M $44.99 130
2015 Q1 12.3M $376M +$44.8M $30.62 114
2014 Q4 10.4M $530M +$22.1M $50.85 120
2014 Q3 9.96M $394M +$11.9M $39.57 108
2014 Q2 9.65M $415M +$52.8M $43.07 96
2014 Q1 8.44M $337M +$157M $39.99 79